Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03767972 · ClinicalTrials.gov registry record · NA

Energy Devices for Rejuvenation

A NA study, sponsored by University of California, Irvine.

Terminated
Registry status
NA
Development phase
24
Enrollment target

NCT03767972 is a NA study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03767972, a NA study, was terminated before completion, sponsored by University of California, Irvine.

TERMINATED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

Non-ablative and ablative devices are the most commonly used minimally-invasive treatments for skin rejuvenation. Current devices on the market for rejuvenation include the lasers such as the Fraxel Restore, the Halo, the Helios III, the Pico, the ThermiVa and the DiVa which have all been shown to have efficacy for the rejuvenation of the face, décolletage, hands and vagina. In this study we propose to compare the efficacy and side effect profile of these devices for skin rejuvenation of various areas of the body including the face, décolletage, hands, trunk, upper and lower extremities, and vagina.

Interventions

  • DEVICE Energy-based device

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-02-01
Est. Completion 2021-09-17
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT03767972

The ClinicalTrials.gov registry entry for NCT03767972 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Energy-based device is the first listed.

NCT03767972 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03767972 about?

NCT03767972 is a clinical study titled "Energy Devices for Rejuvenation". Non-ablative and ablative devices are the most commonly used minimally-invasive treatments for skin rejuvenation. Current devices on the market for rejuvenation include the lasers such as the Fraxel Restore, the Halo, the Helios III, the Pico, the ThermiVa and the DiVa which have all been shown to h...

What is the current status of trial NCT03767972?

This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2018-02-01. Estimated completion is 2021-09-17.

What interventions are being tested in trial NCT03767972?

The interventions under investigation include: Energy-based device (DEVICE).

Who is sponsoring clinical trial NCT03767972?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.